TerrAscend, a Toronto-primarily based vertically integrated marijuana enterprise, reported revenues of 14.six million Canadian dollars ($10.95 million) for the quarter ended March 31, 2019, with a net loss of CA$11.two million.
The enterprise did not report revenues for the comparable quarter in 2018. Its net loss for that period was CA$two.35 million.
For the duration of the quarter, TerrAscend acquired The Apothecarium, a San Francisco-primarily based retailer, in a deal worth additional than $118 million.
TerrAscend trades on the Canadian Securities Exchange below the ticker symbol TER.
Much more particulars on the company’s quarterly benefits can be found right here.